XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of (Loss) Income - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net sales $ 1,832,800,000 $ 1,947,600,000 $ 2,025,300,000
Cost of products sold 1,234,500,000 1,395,300,000 1,410,400,000
Gross profit 598,300,000 552,300,000 614,900,000
Operating costs and expenses:      
Selling, general and administrative expenses 393,500,000 376,700,000 392,600,000
Amortization of intangibles 43,400,000 41,500,000 46,300,000
Restructuring charges 27,200,000 9,600,000 6,000,000
Goodwill impairment 89,500,000 98,700,000 0
Change in fair value of contingent consideration 0 (9,000,000) 19,000,000
Total operating costs and expenses 553,600,000 517,500,000 463,900,000
Operating income [1] 44,700,000 34,800,000 151,000,000
Non-operating expense (income):      
Interest expense 58,600,000 45,600,000 46,300,000
Interest income (7,100,000) (8,300,000) (1,900,000)
Non-operating pension expense (income) 1,800,000 (4,500,000) (7,900,000)
Other expense (income), net 4,500,000 (12,900,000) 3,100,000
(Loss) income before income tax (13,100,000) 14,900,000 111,400,000
Income tax expense 8,700,000 28,100,000 9,500,000
Net (loss) income $ (21,800,000) $ (13,200,000) $ 101,900,000
Per share:      
Basic (loss) income per share $ (0.23) $ (0.14) $ 1.07
Diluted (loss) income per share $ (0.23) $ (0.14) $ 1.05
Weighted average number of shares outstanding:      
Basic (in shares) 95.3 95.3 95.5
Diluted (in shares) [2] 95.3 95.3 97.1
[1] Operating income as presented in the segment table above is defined as i) net sales; ii) less cost of products sold; iii) less SG&A expenses; iv) less amortization of intangibles; v) less restructuring charges; and vi) less change in the fair value of contingent consideration.
[2] Due to the net loss during the twelve months ended December 31, 2023 and 2022, the denominator in the diluted earnings per share calculation does not include the effects of the stock awards for which the average market price for the period exceeds the exercised price, as it would result in a less dilutive computation. As a result, diluted earnings per share for the twelve months ended December 31, 2023 and 2022 are the same as basic earnings per share.